Cargando…

Intranasal Vaccination with Murabutide Enhances Humoral and Mucosal Immune Responses to a Virus-Like Particle Vaccine

Murabutide (MB) is a synthetic immunomodulator recognized by the nucleotide-binding oligomerization domain-containing protein 2 (NOD2) receptor on mammalian cells. MB has previously been approved for testing in multiple human clinical trials to determine its value as an antiviral therapeutic, and as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jackson, Erin M., Herbst-Kralovetz, Melissa M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405106/ https://www.ncbi.nlm.nih.gov/pubmed/22855691 http://dx.doi.org/10.1371/journal.pone.0041529

Ejemplares similares

Norovirus Narita 104 Virus-Like Particles Expressed in Nicotiana benthamiana Induce Serum and Mucosal Immune Responses
por: Mathew, Lolita George, et al.
Publicado: (2014)

Plant-Derived Antigens as Mucosal Vaccines
por: Mason, H. S., et al.
Publicado: (2011)

Potentiating Lung Mucosal Immunity Through Intranasal Vaccination
por: Nelson, Sean A., et al.
Publicado: (2021)

Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice
por: Zhang, Shuo, et al.
Publicado: (2011)

Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice
por: Maltseva, Mariam, et al.
Publicado: (2022)

Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
por: Lee, Young-Tae, et al.
Publicado: (2018)

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
por: Mao, Tianyang, et al.
Publicado: (2022)

An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
por: Schwartzman, Louis M., et al.
Publicado: (2015)

Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
por: An, Xingyue, et al.
Publicado: (2021)

Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
por: Hasegawa, Hideki, et al.
Publicado: (2009)

Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis
por: Boehm, Dylan T., et al.
Publicado: (2019)

Bacterium-Like Particles for Efficient Immune Stimulation of Existing Vaccines and New Subunit Vaccines in Mucosal Applications
por: Van Braeckel-Budimir, Natalija, et al.
Publicado: (2013)

Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques
por: Chua, Brendon Y., et al.
Publicado: (2022)

A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses
por: Liu, Xuejie, et al.
Publicado: (2023)

Unpolarized Release of Vaccinia Virus and HIV Antigen by Colchicine Treatment Enhances Intranasal HIV Antigen Expression and Mucosal Humoral Responses
por: Zhang, Yan, et al.
Publicado: (2011)

Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity
por: Hartwell, Brittany L., et al.
Publicado: (2022)

Intranasally inoculated bacterium-like particles displaying porcine epidemic diarrhea virus S1 protein induced intestinal mucosal immune response in mice
por: Su, Kai, et al.
Publicado: (2023)

Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice
por: King, Deborah F. L., et al.
Publicado: (2015)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

Three-Dimensional Rotating Wall Vessel-Derived Cell Culture Models for Studying Virus-Host Interactions
por: Gardner, Jameson K., et al.
Publicado: (2016)

A recombinant virus-like particle vaccine against adenovirus-7 induces a potent humoral response
por: Mazboudi, Ryan, et al.
Publicado: (2023)

Virus-Like Particle and Nanoparticle Vaccines
por: Kanekiyo, M., et al.
Publicado: (2017)

Intranasal immunization with O-2′-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens
por: Zhao, Kai, et al.
Publicado: (2021)

Virus-like Particle Vaccines and Platforms for Vaccine Development
por: Kheirvari, Milad, et al.
Publicado: (2023)

Novel Vaccine Strategies and Factors to Consider in Addressing Health Disparities of HPV Infection and Cervical Cancer Development among Native American Women
por: Morales, Crystal G., et al.
Publicado: (2022)

Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins
por: Gangadhara, Sailaja, et al.
Publicado: (2017)

Production of virus-like particles for vaccines
por: Fuenmayor, J., et al.
Publicado: (2017)

Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines
por: Yoshino, Naoto, et al.
Publicado: (2023)

Intranasal vaccination with Listeria ivanovii as vector of Mycobacterium tuberculosis antigens promotes specific lung-localized cellular and humoral immune responses
por: Jiang, Ming-juan, et al.
Publicado: (2020)

A single subcutaneous or intranasal immunization with adenovirus‐based SARS‐CoV‐2 vaccine induces robust humoral and cellular immune responses in mice
por: Kim, Eun, et al.
Publicado: (2021)

Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
por: Collins, Katharine A., et al.
Publicado: (2017)

Novel avian paramyxovirus-based vaccine vectors expressing the Ebola virus glycoprotein elicit mucosal and humoral immune responses in guinea pigs
por: Yoshida, Asuka, et al.
Publicado: (2019)

Intranasal Immunization with an Archaeal Lipid Mucosal Vaccine Adjuvant and Delivery Formulation Protects against a Respiratory Pathogen Challenge
por: Patel, Girishchandra B., et al.
Publicado: (2010)

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

Local and systemic immune responses induced by intranasal immunization with biomineralized foot-and-mouth disease virus-like particles
por: Li, Shuo, et al.
Publicado: (2023)

Vaccination to gain humoral immune memory
por: Sarkander, Jana, et al.
Publicado: (2016)

The Humoral Immune Response to BCG Vaccination
por: Tanner, Rachel, et al.
Publicado: (2019)

Virus-Like Particles-Based Mucosal Nanovaccines
por: Rosales-Mendoza, Sergio, et al.
Publicado: (2019)

A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity
por: Adam, Awadalkareem, et al.
Publicado: (2023)

IL-36γ Augments Host Defense and Immune Responses in Human Female Reproductive Tract Epithelial Cells
por: Winkle, Sean M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9nfbkmtuvrjcsai285dv71jq24